ISNUK Competitors

IRD is a French public research institute working for the development of Southern countries, reporting to the Ministries responsible for research and overseas development. IRD is managing for more than sixty years research, consultancy and capacity building activities in Africa, the Mediterranean basin, Asia, Latin America and French overseas territories. IRD researchers address major development challenges regarding environment, sustainable development of living resources, social studies and health. https://youtu.be/MtuGHK6ogR0 🎬 http://lemag.ird.fr/frlUOL

The European Academy of Allergy and Clinical Immunology (EAACI) is a non-profit organization active in the field of allergic and immunologic diseases such as asthma, rhinitis, eczema, occupational allergy, food and drug allergy and anaphylaxis. EAACI was founded in 1956 in Florence and has become the largest medical association in Europe in the field of allergy and clinical immunology. It includes over 12,000 members from 124 countries, as well as 74 National Allergy Societies. EAACI’s mission is to promote basic and clinical research; to collect, assess and diffuse scientific information; to act as a scientific reference body for other scientific, health and political organisations; to encourage and providing training and continuous education, and to collaborate with patients and lay organisations. The Academy aims to provide the most efficient platform for scientific communication and education in the field of allergy and immunology, ultimately striving to ease patients’ lives. EAACI privacy notice: https://www.eaaci.org/privacy-notice.html

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. sitc_log_color.png Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Currently, SITC has more than 2,000 members who represent 22 medical specialties in 42 countries around the world. Through emphasis on high-caliber scientific meetings; dedication to education and outreach activities; focus on initiatives of major importance in the field; and commitment to collaborations with like-minded domestic and international organizations, government and regulatory agencies, associations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.